TRAF3IP2 and coronary artery disorder: Based on this perspective, the relevance of TRAF3IP2 as a biomarker not only in general CAD populations but also in genetically predisposed individuals suggests that TRAF3IP2 can be explored as a prognostic or stratification marker, even in high-risk populations.